Remove 3-biggest-clinical-pharmacy-changes-2017
article thumbnail

The 3 Biggest Clinical Pharmacy Changes From 2017

Med Ed 101

I’m a few days late to the game here, but I wanted to share my 3 biggest clinical pharmacy changes from 2017. My opinion of course, and I’d love it if you would post one or two things below that you felt were important clinical updates in 2017. How did I select these?

40
article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. It is an exciting year… but whether the changes will be a net positive or a net negative is yet to be seen” Maarten Meulenbelt, Partner, Sidley Austin LLP. Key areas of potential legislative change. Risks of limiting orphan drug incentives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The potential of bispecific antibodies in blood cancer care and beyond

Hospital Pharmacy Europe

Bespoke, personalised blood cancer treatment was revolutionised by the approval of the first chimeric antigen receptor (CAR) T-cell therapy in 2017, and they continue to offer an improved quality of life for many patients. Saša Janković finds out more.

article thumbnail

Top 9 Takeaways From 2232 People With Hashimoto’s

The Thyroid Pharmacist

I enrolled in a four-year PharmD program (Doctor of Pharmacy) and became a pharmacist with the goal that one day, I would be able to discover new treatments for people who were suffering. After months of research, I pinpointed lifestyle and dietary changes I could make to heal and reverse my Hashimoto’s.